188
Views
5
CrossRef citations to date
0
Altmetric
Kallman Syndrome

A novel heterozygous intron mutation in SEMA7A causing kallmann syndrome in a female

ORCID Icon, , , ORCID Icon &
Pages 218-221 | Received 21 Apr 2019, Accepted 11 Oct 2019, Published online: 25 Oct 2019

References

  • Dodé C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet. 2009;17(2):139.
  • Hardelin J-P, Dod&Eacute C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev. 2008;2(4–5):181–193.
  • Kim SH. Congenital hypogonadotropic hypogonadism and kallmann syndrome: past, present, and future. Endocrinol Metab. 2015;30(4):456–466.
  • Wierman ME, Kiseljak-Vassiliades K, Tobet S. Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front Neuroendocrinol. 2011;32(1):43–52.
  • Forni PE, Wray S. GnRH, anosmia and hypogonadotropic hypogonadism–where are we? Front Neuroendocrinol. 2015;36:165–177.
  • Boehm U, Bouloux P-M, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547.
  • Ha J-H, Lee S, Kim Y, et al. Kallmann syndrome with a Tyr113His PROKR2 mutation. Medicine. 2017;96(35):e7974.
  • Fukunishi A, Maruyama T, Zhao H, et al. The action of Semaphorin7A on thalamocortical axon branching. J Neurochem. 2011;118(6):1008–1015.
  • Pasterkamp RJ, Peschon JJ, Spriggs MK, et al. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature. 2003;424(6947):398.
  • Messina A, Ferraris N, Wray S, et al. Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet. 2011;20(24):4759–4774.
  • Känsäkoski J, Fagerholm R, Laitinen EM, et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res. 2014;75(5):641.
  • Miura K, Miura S, Yoshiura K, et al. A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1. Hum Reprod. 2010;25(4):1076–1080.
  • Kallmann FJ. The genetic aspects of primary eunuchoidism. Am J Mental Defic. 1944;48:203–236.
  • Ogier JM, Arhatari BD, Carpinelli MR, et al. An intronic mutation in Chd7 creates a cryptic splice site, causing aberrant splicing in a mouse model of CHARGE syndrome. Sci Rep. 2018;8(1):5482.
  • Hwang DY, Hung CC, Riepe FG, et al. CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency. PloS One. 2011;6(9):e25492.
  • Skałba P, Guz M. Hypogonadotropic hypogonadism in women. Endokrynol Pol. 2011;62(6):560–567.
  • Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117(2):457–463.
  • Cole LW, Sidis Y, Zhang CK, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metabol. 2008;93(9):3551–3559.
  • Sarfati J, Guiochon-Mantel A, Rondard P, et al. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metabol. 2010;95(2):659–669.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.